rs756880678
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001005373.4(LRSAM1):c.1913-1G>A variant causes a splice acceptor, intron change. The variant allele was found at a frequency of 0.000018 in 1,613,856 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001005373.4 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRSAM1 | NM_001005373.4 | c.1913-1G>A | splice_acceptor_variant, intron_variant | Intron 24 of 25 | ENST00000300417.11 | NP_001005373.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251272Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135862
GnomAD4 exome AF: 0.0000164 AC: 24AN: 1461708Hom.: 0 Cov.: 31 AF XY: 0.00000963 AC XY: 7AN XY: 727148
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74328
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease Pathogenic:1Uncertain:1
- -
- -
Inborn genetic diseases Pathogenic:1
The c.1913-1G>A intronic variant results from a G to A substitution one nucleotide upstream from coding exon 23 of the LRSAM1 gene. This variant was found to segregate with autosomal recessive Charcot-Marie-Tooth disease, type 2P (CMT2P) in one family. Additionally, RNA studies demonstrated that this alteration results in a transcript expected to trigger nonsense-mediated mRNA decay (Guernsey DL et al. PLoS Genet, 2010 Aug;6). Based on the supporting evidence, this variant is expected to be causative of autosomal recessive CMT2P. However, loss of function of LRSAM1 has not been established as a mechanism of disease for autosomal dominant CMT2P, so the clinical significance for autosomal dominant CMT2P is unclear. -
not provided Pathogenic:1
DNA sequence analysis of the LRSAM1 gene demonstrated a sequence change in the canonical splice acceptor site of intron 23, c.1913-1G>A. This pathogenic sequence change is predicted to disrupt RNA splicing and likely to result in an absent or disrupted protein product (PMID: 20865121). This sequence change has been described in the gnomAD database with a low frequency of 0.005% in the European sub-population (dbSNP rs756880678). The majority of pathogenic variants in LRSAM1 are present in the heterozygous state and cause an autosomal dominant phenotype. However, this sequence change has been previously reported in the homozygous state segregating with disease in six affected individuals from one consanguineous family (PMID: 20865121). -
Charcot-Marie-Tooth disease axonal type 2P Pathogenic:1
This sequence change affects an acceptor splice site in intron 23 of the LRSAM1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and may result in an absent or altered protein product. This variant is present in population databases (rs756880678, gnomAD 0.003%). Disruption of this splice site has been observed in individual(s) with autosomal recessive Charcot-Marie-Tooth disease (PMID: 20865121). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 204301). Studies have shown that disruption of this splice site results in altered splicing, and produces a non-functional protein and/or introduces a premature termination codon (PMID: 20865121). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at